BioCardia, Inc. (BCDA)
NASDAQ: BCDA · IEX Real-Time Price · USD
0.376
-0.018 (-4.52%)
At close: May 1, 2024, 4:00 PM
0.360
-0.016 (-4.25%)
Pre-market: May 2, 2024, 5:20 AM EDT

BioCardia Revenue

In the year 2023, BioCardia had annual revenue of $477.00K, a decrease of -64.72%. Revenue in the quarter ending December 31, 2023 was $13.00K, a -87.74% decrease year-over-year.

Revenue (ttm)
$477.00K
Revenue Growth
-64.72%
P/S Ratio
21.19
Revenue / Employee
$29,813
Employees
16
Market Cap
10.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023477.00K-875.00K-64.72%
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019710.00K85.00K13.60%
Dec 31, 2018625.00K146.00K30.48%
Dec 31, 2017479.00K-97.00K-16.84%
Dec 31, 2016576.00K-328.00K-36.28%
Dec 31, 2015904.00K477.00K111.71%
Dec 31, 2014427.00K159.00K59.33%
Dec 31, 2013268.00K206.00K332.26%
Dec 31, 201262.00K50.00K416.67%
Dec 31, 201112.00K--
Dec 31, 20100--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Telesis Bio 27.51M
Guardion Health Sciences 12.25M
Aeterna Zentaris 4.50M
Addex Therapeutics 1.96M
Inhibikase Therapeutics 260.50K
Revenue Rankings